2019
DOI: 10.1016/j.jtos.2019.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Hyperlipidemia induces meibomian gland dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
42
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 57 publications
(45 citation statements)
references
References 52 publications
3
42
0
Order By: Relevance
“…The pathophysiological and molecular mechanisms between MGD and dyslipidemia have not been fully understood. The study by Bu et al 50 found that ApoE knockout mice that were a hypercholesterolemia animal model showed meibomian gland obstruction with meibomian gland atrophy. The ApoE knockout mice also showed increased inflammatory cell infiltration, abnormal meibomian gland acinar cell proliferation, and excessive keratinization in the meibomian gland.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The pathophysiological and molecular mechanisms between MGD and dyslipidemia have not been fully understood. The study by Bu et al 50 found that ApoE knockout mice that were a hypercholesterolemia animal model showed meibomian gland obstruction with meibomian gland atrophy. The ApoE knockout mice also showed increased inflammatory cell infiltration, abnormal meibomian gland acinar cell proliferation, and excessive keratinization in the meibomian gland.…”
Section: Discussionmentioning
confidence: 99%
“…The ApoE knockout mice also showed increased inflammatory cell infiltration, abnormal meibomian gland acinar cell proliferation, and excessive keratinization in the meibomian gland. 50 However, there is no molecular biology study to research the pathophysiological and molecular mechanisms in older patients. In this study, our subjects had an average age of 72.46 ± 10.30 years, which is the age in which the MG tends to atrophy.…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, several clinical studies have demonstrated that moderate-to-severe MGD was associated with high total cholesterol and low-density lipoprotein blood levels [85,86]. Thereafter, dyslipidemic animal models were used to study the Meibomian gland and, more specifically, MGD [87][88][89]. To investigate whether systemic lipid disorders can be associated with DED and/or MGD, a study used three transgenic adult mice models, apolipoprotein-E knockout (APOE-KO), low-density lipoprotein receptor knockout (LDLR-KO) and a mouse model with overexpression of human apolipoprotein CIII (ApoCIIIKI), compared to age-and gender-matched C57BL/6 mice [87].…”
Section: Association Between Dyslipidemia and Mgdmentioning
confidence: 99%
“…Apolipoprotein E knockout (ApoE −/− ) mice are characterized by a marked increase in total plasma cholesterol levels and develop microvasculature lesions; making ApoE −/− mice a possible model for studying the mechanisms of hyperlipidemia and atherosclerosis in MGD and DED [91]. Recently, Bu et al [89] found that ApoE −/− mice present hypertrophic eyelids at 5 and 7 months of age, which was accompanied by Meibomian gland dropout and disordered acini and ducts in both upper and lower eyelids, when compared to age-matched control mice. These mice also present punctate corneal staining and signs of corneal damage, all clinical features of MGD [89].…”
Section: Association Between Dyslipidemia and Mgdmentioning
confidence: 99%
See 1 more Smart Citation